In this Issue
PLUS: An introduction to the new Chief!
Letter from the Chief
By Azeem Latib, MD
Guest Chief Medical Editors’ Page
By Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC; and Samir Kapadia, MD, FACC, FSCAI
Evaluating new clinical trial data to better understand the benefits and limitations of TAVR in patients at low surgical risk.
By Lars Søndergaard, MD, DMSc; and Nicolo Piazza, MD, PhD
Experts discuss the significance of recent data and the potential impact on their practice.
With Kentaro Hayashida, MD, PhD, FESC, FACC, FJCS; Robert Ostfeld, MD, MSc, FACC; Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC; Michael J. Reardon, MD; and Steven J. Yakubov, MD, FACC, FSCAI
A discussion of what defines durability, an overview of the surgical and transcatheter experience to date, and future directions.
By Faisal Khan, MBBS; and Stephan Windecker, MD
A report of findings from registries and large cohorts.
By Hasan Rehman, MD; Neal S. Kleiman, MD, FACC, MSCAI; and Ankur Kalra, MD, FACP, FACC, FSCAI
An overview of the current data and technical considerations for transcatheter intervention in bicuspid aortic valves.
By Didier Tchétché, MD
A review of the technical challenges and optimal valve choices in different clinical and anatomic scenarios.
By Noman Ali, PhD; and Daniel J. Blackman, MD
Reviewing the current landscape of permanent pacemaker implantation post-TAVR and a look at the road ahead.
By Rahul Sharma, MD; and Rahul P. Sharma, MD
FEATURED PROGRAMSponsored by Philips
SymphonySuite and Diamond Select support the entrepreneur.
With Jihad A. Mustapha, MD, FACC, FSCAI; and Fadi Saab, MD, FASE, FACC, FSCAI
EUROPEAN FEATURED TECHNOLOGYSponsored by Teleflex
Using a dual lumen catheter to accurately measure pressures between two sites across a valve or stenosis.
By Christian Bradaric, MD
A step-by-step practical guide for performing BVF to facilitate ViV TAVR.
By Ahmed Almomani, MD; and Adnan K. Chhatriwalla, MD
CODING & REIMBURSEMENT
MedAxiom survey results indicate emerging trends in leadership, staffing, and economics of structural heart programs.
By Ginger Biesbrock, PA-C, MPH, MPAS, AACC
Dr. Dahle shares her thoughts on the current and emerging technologies for valvular disease, as well as her advice for new surgeons entering the field.